Director Schurfeld buys 3,500 shares at $1.59–$1.64 as SURG stock trades -83.7% from 52-week high
Richard Earl Schurfeld, a director, executed 2 separate purchases totaling 3,500 shares for $5,593.42 on 2024-11-15, increasing his holdings from 44,001 to 47,501 shares (+8.0%). The buys occurred at a blended average price of $1.60, but the current stock price is $1.46, already down -22.3% over the past 30 days and trading -83.7% from its 52-week high of $8.97. Schurfeld's prior buy at this ticker on 2024-09-13 generated a +36.7% 30-day return, though the company's fundamentals present headwinds: the latest quarter showed revenue of $4,769,697.00 against a net loss of $-14,275,347.00. The insider's cross-ticker track record shows 1 prior buy with avg 30d return +36.7%, suggesting some historical success in timing entry points, but absence of measurable 90-day outcomes on recent same-ticker trades leaves conviction timing on this filing unvalidated at the longer horizon.